A Comparison of Single and Combined Schemes of Asia-Pacific Colorectal Screening, Faecal Immunochemical and Stool Deoxyribonucleic Acid Testing for Community Colorectal Cancer Screening

References

• Siegel RL, Miller KD, Goding Sauer A, et al. Colorectal cancer statistics, 2020. CA Cancer J Clin. 2020;70(3):145–164. doi:10.3322/caac.21601
   PubMed Web of Science ®Google Scholar
• Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet. 2019;394(10207):1467–1480. doi:10.1016/S0140-6736(19)32319-0
   PubMed Web of Science ®Google Scholar
• Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol. 2022;19(8):521–531. doi:10.1038/s41575-022-00612-y
   PubMed Web of Science ®Google Scholar
• Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369(12):1106–1114. doi:10.1056/NEJMoa1300720
   PubMed Web of Science ®Google Scholar
• Travis E, Ashley L, Pownall M, O’Connor DB. Barriers to flexible sigmoidoscopy colorectal cancer screening in low uptake socio-demographic groups: a systematic review. Psychooncology. 2020;29(8):1237–1247. doi:10.1002/pon.5443
   PubMed Web of Science ®Google Scholar
• Hoeck S, Van Roy K, Willems S. Barriers and facilitators to participate in the colorectal cancer screening programme in Flanders (Belgium): a focus group study. Acta Clin Belg. 2022;77(1):37–44. doi:10.1080/17843286.2020.1783906
   PubMed Web of Science ®Google Scholar
• Luque JS, Vargas M, Wallace K, et al. Engaging the community on colorectal cancer screening education: focus group discussions among African Americans. J Cancer Educ. 2022;37(2):251–262. doi:10.1007/s13187-021-02019-w
   PubMed Web of Science ®Google Scholar
• Yeoh KG, Ho KY, Chiu HM, et al.; Asia-Pacific Working Group on Colorectal Cancer. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects. Gut. 2011;60(9):1236–1241. doi:10.1136/gut.2010.221168
   PubMed Web of Science ®Google Scholar
• Chen H, Lu M, Liu C, et al. Comparative evaluation of participation and diagnostic yield of colonoscopy vs fecal immunochemical test vs risk-adapted screening in colorectal cancer screening: interim analysis of a multicenter randomized controlled trial (TARGET-C). Am J Gastroenterol. 2020;115(8):1264–1274. doi:10.14309/ajg.0000000000000624
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Gruber RN, Stump TE, Emmett TW, Monahan PO. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and meta-analysis. Ann Intern Med. 2019;170(5):319–329. doi:10.7326/M18-2390
   PubMed Web of Science ®Google Scholar
• Meklin J, Syrjänen K, Eskelinen M. Colorectal cancer screening with traditional and new-generation fecal immunochemical tests: a critical review of fecal occult blood tests. Anticancer Res. 2020;40(2):575–581. doi:10.21873/anticanres.13987
   PubMed Web of Science ®Google Scholar
• van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology. 2008;135(1):82–90. doi:10.1053/j.gastro.2008.03.040
   PubMed Web of Science ®Google Scholar
• Wang J, Liu S, Wang H, et al. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study. Clin Epigenetics. 2020;12(1):162. doi:10.1186/s13148-020-00954-x
   PubMed Web of Science ®Google Scholar
• Bibbins-Domingo K, Grossman DC, Curry SJ, et al.; US Preventive Services Task Force. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA. 2016;315(23):2564–2575. doi:10.1001/jama.2016.5989
   PubMed Web of Science ®Google Scholar
• Niu F, Wen J, Fu X, et al. Stool DNA test of methylated syndecan-2 for the early detection of colorectal neoplasia. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1411–1419. doi:10.1158/1055-9965.EPI-17-0153
   PubMed Web of Science ®Google Scholar
• Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med. 1997;126(10):811–822. doi:10.7326/0003-4819-126-10-199705150-00014
   PubMed Web of Science ®Google Scholar
• Singal AG, Gupta S, Skinner CS, et al. Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial. JAMA. 2017;318(9):806–815. doi:10.1001/jama.2017.11389
   PubMed Web of Science ®Google Scholar
• Carethers JM. Fecal DNA testing for colorectal cancer screening. Annu Rev Med. 2020;71:59–69. doi:10.1146/annurev-med-103018-123125
   PubMed Web of Science ®Google Scholar
• Sharma T. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults. Public Health. 2020;182:70–76. doi:10.1016/j.puhe.2020.01.021
   PubMed Web of Science ®Google Scholar
• Jin P, You P, Fang J, et al. Comparison of performance of two stool DNA tests and a fecal immunochemical test in detecting colorectal neoplasm: a multicenter diagnostic study. Cancer Epidemiol Biomarkers Prev. 2022;31(3):654–661. doi:10.1158/1055-9965.EPI-21-0991
   PubMed Web of Science ®Google Scholar
• Young GP, Symonds EL, Allison JE, et al. Advances in fecal occult blood tests: the FIT revolution. Dig Dis Sci. 2015;60(3):609–622. doi:10.1007/s10620-014-3445-3
   PubMed Web of Science ®Google Scholar
• Digestive Endoscopy Special Committee of Endoscopic Physicians Branch of Chinese Medical Association; Cancer Endoscopy Committee of China Anti-Cancer Association. 中国消化内镜诊疗相关肠道准备指南(2019 上海)[Chinese guideline for bowel preparation for colonoscopy (2019, Shanghai)], Zhonghua Nei Ke Za Zhi. 2019;58(7):485–495. Chinese. doi:10.3760/cma.j.issn.0578-1426.2019.07.002
   PubMedGoogle Scholar
• He XX, Yuan SY, Li WB, et al. Improvement of Asia-Pacific colorectal screening score and evaluation of its use combined with fecal immunochemical test. BMC Gastroenterol. 2019;19(1):226. doi:10.1186/s12876-019-1146-2
   PubMed Web of Science ®Google Scholar
• Wang Z, Shang J, Zhang G, et al. Evaluating the clinical performance of a dual-target stool DNA test for colorectal cancer detection. J Mol Diagn. 2022;24(2):131–143. doi:10.1016/j.jmoldx.2021.10.012
   PubMed Web of Science ®Google Scholar
• Han YD, Oh TJ, Chung TH, et al. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA. Clin Epigenetics. 2019;11(1):51. doi:10.1186/s13148-019-0642-0
   PubMedGoogle Scholar
• Su WC, Kao WY, Chang TK, et al. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Biosci Rep. 2021;41(1)):BSR20201930. doi:10.1042/BSR20201930
   PubMed Web of Science ®Google Scholar
• Malagón M, Ramió-Pujol S, Serrano M, et al. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population. PLoS One. 2020;15(12):e0243158. doi:10.1371/journal.pone.0243158
   PubMed Web of Science ®Google Scholar
• Dong J, Ma TS, Xu YH, et al. Characteristics and potential malignancy of colorectal juvenile polyps in adults: a single-center retrospective study in China. BMC Gastroenterol. 2022;22(1):75. doi:10.1186/s12876-022-02151-x
   PubMed Web of Science ®Google Scholar
• Mo S, Wang H, Han L, et al. Fecal multidimensional assay for non-invasive detection of colorectal cancer: fecal immunochemical test, stool DNA mutation, methylation, and intestinal bacteria analysis. Front Oncol. 2021;11:643136. doi:10.3389/fonc.2021.643136
   PubMed Web of Science ®Google Scholar
• Bai Y, Liu J, Kang Q, et al. Value of the methylation status of SDC2 and SFRP2 for colorectal cancer screening. Chin J Dig Endosc. 2019;36(6):427–432. doi:10.3760/cma.j.issn.1007-5232.2019.06.009
   Google Scholar
• Luu XQ, Lee K, Kim J, Sohn DK, Shin A, Choi KS. The classification capability of the Asia Pacific Colorectal Screening score in Korea: an analysis of the Cancer Screenee Cohort. Epidemiol Health. 2021;43:e2021069. doi:10.4178/epih.e2021069
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Mannalithara A. Comparative effectiveness and cost effectiveness of a multitarget stool DNA test to screen for colorectal neoplasia. Gastroenterology. 2016;151(3):427–439.e6. doi:10.1053/j.gastro.2016.06.003
   PubMed Web of Science ®Google Scholar